MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Hervé Dombret Juliette Lambert Aline Renneville Philippe Rousselot Olivier Nibourel Cécile Pautas Christine Terré Sylvie Castaigne Sandrine Hayette Claude Preudhomme |
| Publication date | August 1, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |